Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals develops treatments for Prader-Willi syndrome, a rare genetic disorder characterized by hyperphagia and obesity.
10-KSep 28Latest SEC filing
Aug 4Latest story
Sign inSign inRhythm Pharmaceuticals develops treatments for Prader-Willi syndrome, a rare genetic disorder characterized by hyperphagia and obesity.